1. Incidence of hypocalcemia in patients receiving denosumab for prevention of skeletal-related events in bone metastasis. (April 2017) Authors: Yerram, Prakirthi; Kansagra, Shraddha; Abdelghany, Osama Journal: Journal of oncology pharmacy practice Issue: Volume 23:Number 3(2017) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Incidence of skeletal related events in patients with bone metastasis receiving denosumab every four weeks compared to intervals greater than every four weeks. (April 2019) Authors: Yerram, Prakirthi; Moore, Russell; Wolf, Steven; Barbour, Sally Y Journal: Journal of oncology pharmacy practice Issue: Volume 25:Number 3(2019) Page Start: 529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City. (March 2021) Authors: Yerram, Prakirthi; Thackray, Jennifer; Modelevsky, Lisa R; Land, Josiah D; Reiss, Samantha N; Spatz, Krisoula H; Levoir, Andrea C; Pak, Terry K; Dao, Phuong H; Buege, Michael J; Derespiris, Lauren M; Lau, Carmen; Orozco, Jennifer S; Boparai, Manpreet; Koranteng, Lauren A; Reichert, Kate E; Yan, S... Journal: Journal of oncology pharmacy practice Issue: Volume 27:Number 2(2021) Page Start: 389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PATH-33. GERMLINE PREDICTORS OF HEMATOLOGIC TOXICITY IN PATIENTS WITH GLIOMA TREATED WITH CHEMOTHERAPY. (11th November 2019) Authors: Sener, Ugur; Bhatia, Ankush; DeAngelis, Lisa; Mandelker, Diana; Yerram, Prakirthi Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. RARE-51. RITUXIMAB, METHOTREXATE, BCNU, ETOPOSIDE, AND PREDNISONE (RMBVP) FOR THE TREATMENT OF RELAPSED/RECURRENT PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE SINGLE CENTER STUDY. (11th November 2019) Authors: Reiss, Samantha; Yerram, Prakirthi; Modelevsky, Lisa; Grommes, Christian Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas. Issue 1 (19th December 2017) Authors: Reiss, Samantha N.; Yerram, Prakirthi; Modelevsky, Lisa; Grommes, Christian Journal: Journal for immunotherapy of cancer Issue: Volume 5:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study. Issue 3 (23rd February 2022) Authors: Reiss, Samantha N.; Yerram, Prakirthi; Modelevsky, Lisa; Grommes, Christian Journal: Leukemia & lymphoma Issue: Volume 63:Issue 3(2022) Page Start: 627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Use of naloxone for reversal of life-threatening opioid toxicity in cancer-related pain. (February 2016) Authors: Howlett, Christina; Gonzalez, Rosa; Yerram, Prakirthi; Faley, Brian Journal: Journal of oncology pharmacy practice Issue: Volume 22:Number 1(2016:Mar.) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗